{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-9119", "postId": 9119, "name": "Phreesia, Inc.", "description": "Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Phreesia, Inc. (\u201cPhreesia\u201d or the \u201cCompany\u201d) (NYSE: PHR) and reminds investors of the July 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Phreesia\u2019s slowing demand and reduced visibility in key revenue streams, notably, the weakened pharmaceutical marketing commitments in its Network Solutions segment. Lead Plaintiff Deadline: July 13, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "PHR", "legal": { "court": "United States District Court for the District of Delaware", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "05/08/2025", "end": "03/30/2026" }, "leadPlaintiffDeadline": "07/13/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/phreesia-inc/", "canonicalUrl": "https://faruqilaw.com/case/phreesia-inc/", "datePublished": "2026-05-13T21:41:37+00:00", "dateModified": "2026-05-13T21:41:37+00:00", "associatedOrganization": { "@id": "case-9119-org" }, "legalService": { "@id": "case-9119-legalservice" }, "hasPart": [ { "@id": "case-9119-faq" }, { "@id": "case-9119-press-list" } ], "legalRepresentation": [ { "@id": "case-9119-attorney-516" }, { "@id": "case-9119-attorney-506" } ] }, { "@type": "Organization", "@id": "case-9119-org", "name": "Phreesia, Inc.", "identifier": "PHR", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://www.phreesia.com/" }, { "@type": "LegalService", "@id": "case-9119-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-9119-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-9119-legalservice" } }, { "@type": "Person", "@id": "case-9119-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-9119-legalservice" } }, { "@type": "FAQPage", "@id": "case-9119-faq", "mainEntity": [ { "@type": "Question", "name": "Why is Phreesia facing a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors allege Phreesia made misleading statements about demand trends and revenue visibility within its business operations." } }, { "@type": "Question", "name": "What are investors claiming about Phreesia\u2019s demand trends?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges the company concealed slowing demand that negatively affected growth expectations." } }, { "@type": "Question", "name": "What is the Network Solutions segment mentioned in the Phreesia lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Network Solutions is a business segment tied to healthcare marketing and pharmaceutical-related revenue streams." } }, { "@type": "Question", "name": "Why are pharmaceutical marketing commitments important to Phreesia investors?", "acceptedAnswer": { "@type": "Answer", "text": "These commitments contribute to revenue growth, and weaker demand may reduce future earnings potential." } }, { "@type": "Question", "name": "What are investors alleging Phreesia failed to disclose?", "acceptedAnswer": { "@type": "Answer", "text": "Plaintiffs claim the company did not fully reveal weakening pharmaceutical marketing activity and reduced revenue visibility." } }, { "@type": "Question", "name": "How could slowing demand affect Phreesia\u2019s financial performance?", "acceptedAnswer": { "@type": "Answer", "text": "Reduced customer demand can lower revenue growth, weaken guidance, and impact profitability." } }, { "@type": "Question", "name": "What does \u201creduced revenue visibility\u201d mean in the Phreesia lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "It refers to uncertainty about future revenue streams and the company\u2019s ability to forecast growth accurately." } }, { "@type": "Question", "name": "Why are growth projections important for Phreesia investors?", "acceptedAnswer": { "@type": "Answer", "text": "Investors rely on company guidance and demand trends to evaluate future business performance and valuation." } }, { "@type": "Question", "name": "How could weakened marketing commitments impact Phreesia\u2019s stock price?", "acceptedAnswer": { "@type": "Answer", "text": "If revenue opportunities decline, investor expectations may fall, potentially leading to stock price drops." } }, { "@type": "Question", "name": "Who may qualify to participate in the Phreesia class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased Phreesia securities between May 8, 2025 and March 30, 2026 may be eligible if they suffered losses." } }, { "@type": "Question", "name": "What is the deadline to seek lead plaintiff status in the Phreesia lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors seeking appointment as lead plaintiff must file a motion by July 13, 2026." } }, { "@type": "Question", "name": "What is a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "A securities class action allows investors to collectively pursue claims against a company for misleading statements or omissions." } }, { "@type": "Question", "name": "What does the term \u201cclass period\u201d mean in a securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The class period is the timeframe when alleged misleading statements occurred and investors may have purchased shares." } }, { "@type": "Question", "name": "What is a lead plaintiff in a securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "The lead plaintiff is the investor selected by the court to represent the interests of all shareholders in the case." } }, { "@type": "Question", "name": "How do investors receive compensation from a securities class action settlement?", "acceptedAnswer": { "@type": "Answer", "text": "If a settlement is reached, investors submit claim forms documenting their trades to receive a portion of the settlement fund." } } ] }, { "@type": "NewsArticle", "@id": "case-9119-press-1", "headline": "Phreesia: Market Delivers A Resounding Vote Of No Confidence (Rating Downgrade)", "url": "https://seekingalpha.com/article/4888832-phreesia-market-delivers-a-resounding-vote-of-no-confidence-rating-downgrade", "datePublished": "2026-04-07" }, { "@type": "NewsArticle", "@id": "case-9119-press-2", "headline": "Why Phreesia Stock Flopped Today", "url": "https://www.fool.com/investing/2026/03/31/why-phreesia-stock-flopped-today/", "datePublished": "2026-03-31" }, { "@type": "NewsArticle", "@id": "case-9119-press-3", "headline": "Phreesia Inc. (PHR) Stock Falls on Q4 2026 Earnings", "url": "https://www.quiverquant.com/news/Phreesia+Inc.+%28PHR%29+Stock+Falls+on+Q4+2026+Earnings", "datePublished": "2026-03-30" }, { "@type": "NewsArticle", "@id": "case-9119-press-4", "headline": "Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?", "url": "https://finance.yahoo.com/markets/stocks/articles/phreesia-phr-stock-jumps-5-093800389.html", "datePublished": "2026-03-20" }, { "@type": "NewsArticle", "@id": "case-9119-press-5", "headline": "Phreesia price target lowered to $30 from $35 at DA Davidson", "url": "https://finance.yahoo.com/news/phreesia-price-target-lowered-30-135513459.html", "datePublished": "2026-01-24" }, { "@type": "NewsArticle", "@id": "case-9119-press-6", "headline": "Wells Fargo initiates Phreesia stock with Overweight rating, $30 price target", "url": "https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-phreesia-stock-with-overweight-rating-30-price-target-93CH-4439027", "datePublished": "2026-01-09" }, { "@type": "ItemList", "@id": "case-9119-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-9119-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-9119-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-9119-press-3" } }, { "@type": "ListItem", "position": 4, "item": { "@id": "case-9119-press-4" } }, { "@type": "ListItem", "position": 5, "item": { "@id": "case-9119-press-5" } }, { "@type": "ListItem", "position": 6, "item": { "@id": "case-9119-press-6" } } ] } ] }

Phreesia, Inc.

Phreesia, Inc.

Join Action
Case Details
Ticker PHR
Class Period 05/08/2025 - 03/30/2026
Lead Plaintiff Deadline 07/13/2026
Days Left to Seek Plaintiff
60

If you are a Phreesia investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR) and reminds investors of the July 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Phreesia’s slowing demand and reduced visibility in key revenue streams, notably, the weakened pharmaceutical marketing commitments in its Network Solutions segment.

📞 Lead Plaintiff Deadline: July 13, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Phreesia, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771